Compounds > oxyphenbutazone
Page last updated: 2024-11-02

oxyphenbutazone and Lung Diseases

oxyphenbutazone has been researched along with Lung Diseases in 9 studies

Oxyphenbutazone: A non-steroidal anti-inflammatory drug. Oxyphenbutazone eyedrops have been used abroad in the management of postoperative ocular inflammation, superficial eye injuries, and episcleritis. (From AMA, Drug Evaluations Annual, 1994, p2000) It had been used by mouth in rheumatic disorders such as ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis but such use is no longer considered justified owing to the risk of severe hematological adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p27)
oxyphenbutazone : A metabolite of phenylbutazone obtained by hydroxylation at position 4 of one of the phenyl rings. Commonly used (as its hydrate) to treat pain, swelling and stiffness associated with arthritis and gout, it was withdrawn from the market 1984 following association with blood dyscrasis and Stevens-Johnson syndrome.

Lung Diseases: Pathological processes involving any part of the LUNG.

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19909 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
ALIXTRUEBA, A1
CUETARA, M1
Cameron, DC1
James, DG3
Carstairs, LS2
Trowell, J1
Sharma, OP4
Müller-Fassbender, H1
Klein, U1
Bablath, H1
Heinze, HG1
Siltzbach, LE1

Reviews

1 review available for oxyphenbutazone and Lung Diseases

ArticleYear
Sarcoidosis.
    Disease-a-month : DM, 1970

    Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aminobenzoates; Child; Child, Preschool; Diagnosis, Diff

1970

Trials

3 trials available for oxyphenbutazone and Lung Diseases

ArticleYear
Treatment of sarcoidosis. Report of a controlled therapeutic trial.
    Lancet (London, England), 1967, Sep-09, Volume: 2, Issue:7515

    Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Female; Humans; Lung Diseases; Male; Middle Aged;

1967
Treatment of sarcoidosis.
    The American review of respiratory disease, 1972, Volume: 105, Issue:5

    Topics: Clinical Trials as Topic; Humans; Lung Diseases; Oxyphenbutazone; Sarcoidosis

1972
[Effect of oxyphenbutazone on radiation-induced lung diseases].
    Medizinische Klinik, 1973, Apr-13, Volume: 68, Issue:15

    Topics: Adult; Aged; Breast Neoplasms; Bronchography; Female; Humans; Lung Diseases; Middle Aged; Oxyphenbut

1973

Other Studies

5 other studies available for oxyphenbutazone and Lung Diseases

ArticleYear
[THE USE OF ANTIPHLOGISTIC DRUGS (DERIVATIVES OF PHENYLBUTAZONE) IN THE POSTOPERATIVE TREATMENT IN THORACIC SURGERY].
    Revista clinica espanola, 1964, May-15, Volume: 93

    Topics: Humans; Lung Diseases; Oxyphenbutazone; Phenylbutazone; Postoperative Care; Surgical Procedures, Ope

1964
[Pulmonary adverse effects of oxyphenbutazone].
    Lakartidningen, 1977, May-25, Volume: 74, Issue:21

    Topics: Adult; Aged; Female; Humans; Lung; Lung Diseases; Male; Middle Aged; Oxyphenbutazone

1977
Letter: diffuse pulmonary disorder caused by oxyphenbutazone.
    British medical journal, 1975, May-31, Volume: 2, Issue:5969

    Topics: Aged; Drug Hypersensitivity; Female; Humans; Lung Diseases; Oxyphenbutazone

1975
Sarcoidosis in the aged.
    Geriatrics, 1973, Volume: 28, Issue:1

    Topics: Age Factors; Aged; Alkaline Phosphatase; Aminobenzoates; Black or African American; Blood Proteins;

1973
A tale of two cities: a comparison of sarcoidosis in London and New York.
    Archives of internal medicine, 1969, Volume: 123, Issue:2

    Topics: Adult; Age Factors; Black People; Chloroquine; Diagnosis, Differential; Eye Manifestations; Female;

1969